The purpose of the RISE Program at Xavier University of Louisiana is to increase the number of African American students who choose careers in biomedical research. Toward this end, we have designed a program with the following goals: 1) Stimulate interest of African American students in biomedical research careers, 2) Increase the number of Xavier RISE students entering graduate programs in biomedical research areas, and 3) Increase retention in the biomedical sciences at Xavier University. In an effort to attain these goals, we will continue to provide an integrated, developmental program in which our students participate in both intramural and extramural laboratory research projects, attend an interdisciplinary seminar series, and take part in journal clubs and career roundtables. We will also provide instruction in the skills necessary to help students gain acceptance into and do well in biomedical graduate programs. These skills include library researching, technical writing, oral presentations, and a thorough understanding of health ethics and responsible conduct in research. We are also introducing a new program focus that will build upon a university-wide initiative to increase retention in the sciences and mathematics through evaluation and improvement of sophomore-level science and mathematics courses, as well as faculty workshops on effective undergraduate research student mentoring. This funding will allow Xavier to leverage institutional and federal funding to strengthen its student enhancement initiatives and systematically improve each individual student's ability to successfully enter and complete a graduate program in the biomedical sciences. ! ! !
There is a significant national shortage of African Americans in the biomedical research workforce. Xavier University is positioned to play a unique and important role in producing leaders to meet current and projected future demands for science professionals needed to work in biomedical fields. !
|Ponnapakkam, Tulasi; Saulsberry, Tyjah; Hill, Tarius et al. (2018) Inhibition of breast tumor growth in mice after treatment with ceramide analog 315. Anticancer Drugs 29:898-903|
|Dai, Lu; Smith, Charles D; Foroozesh, Maryam et al. (2018) The sphingosine kinase 2 inhibitor ABC294640 displays anti-non-small cell lung cancer activities in vitro and in vivo. Int J Cancer 142:2153-2162|
|Foroozesh, Maryam; Goyal, Navneet; Jackson, Taylor et al. (2017) OPTIMIZATION OF SCALE-UP SYNTHESIS OF ANTI-CANCER CERAMIDE ANALOG 315. J Undergrad Chem Res 16:89-90|
|Komati, Rajesh; Spadoni, Dominick; Zheng, Shilong et al. (2017) Ligands of Therapeutic Utility for the Liver X Receptors. Molecules 22:|
|Riley, Kevin E; Tran, Khanh-An (2017) Strength, character, and directionality of halogen bonds involving cationic halogen bond donors. Faraday Discuss 203:47-60|
|Powell, David; Chandra, Sruti; Dodson, Kyra et al. (2017) Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer. Eur J Pharm Biopharm 114:108-118|
|Carriere, Patrick P; Llopis, Shawn D; Naiki, Anna C et al. (2016) Glyceollin I Reverses Epithelial to Mesenchymal Transition in Letrozole Resistant Breast Cancer through ZEB1. Int J Environ Res Public Health 13:ijerph13010010|
|Singleton, Chelsea R; Affuso, Olivia; Sen, Bisakha (2016) Decomposing Racial Disparities in Obesity Prevalence: Variations in Retail Food Environment. Am J Prev Med 50:365-372|
|Yao, Xin; Pham, Tri; Temple, Brandi et al. (2016) The Anoikis Effector Bit1 Inhibits EMT through Attenuation of TLE1-Mediated Repression of E-Cadherin in Lung Cancer Cells. PLoS One 11:e0163228|
|Riley, Kevin E; Vazquez, Mariela; Umemura, Cole et al. (2016) Exploring the (Very Flat) Potential Energy Landscape of R-Br???? Interactions with Accurate CCSD(T) and SAPT Techniques. Chemistry 22:17690-17695|
Showing the most recent 10 out of 18 publications